The percentage of U.S. adults reporting long COVID symptoms has fallen since the summer of 2022, but some people say they are still coping with changes to daily life brought on by the condition, ...
A large, prospective US study has identified eight distinct long-COVID trajectories, highlighting the diverse manifestations ...
The vast majority of New York adults who get COVID-19 end up experiencing at least one symptom for a month or longer, according to state health officials. Results from a survey conducted in late 2022 ...
(CNN) — The percentage of US adults reporting long Covid symptoms has fallen since the summer of 2022, but some people say they are still coping with changes to daily life brought on by the condition, ...
Simnotrelvir is an oral 3-chymotrypsin–like protease inhibitor that has been found to have in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and potential efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback